What Researchers Did
Researchers prospectively evaluated patient-reported outcomes in 57 women receiving hyperbaric oxygen therapy for late radiation-induced tissue toxicity after breast-conserving therapy.
What They Found
Before treatment, severe complaints ranged from 14% (swollen arm/hand) to 67% (breast pain), which significantly decreased post-HBOT to 7% and 15% respectively. Overall, 81% of patients reported at least a 1-point improvement in their NRS pain score, indicating positive patient-reported outcomes.
What This Means for Canadian Patients
Canadian breast cancer patients experiencing late radiation-induced tissue toxicity may find hyperbaric oxygen therapy to be an effective treatment option for reducing severe symptoms. This therapy could potentially improve their quality of life by alleviating pain, swelling, and mobility issues.
Canadian Relevance
This study was conducted outside of Canada, and therefore has no direct Canadian connection.
Study Limitations
A limitation of this study is the absence of a control group, which prevents direct comparison of HBOT efficacy against other treatments or no intervention.